Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study

Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study

Background: Desensitization strategies improve access to transplantation in highly sensitized kidney transplant candidates. Tocilizumab could be a valuable addition to more traditional desensitization regimens. We investigated the effect of tocilizumab as an add-on therapy to our standard of care (S...

Full description

Bibliographic Details
Main Authors: Thomas Jouve, Mélanie Daligault, Johan Noble, Florian Terrec, Farida Imerzoukene, Céline Dard, Béatrice Bardy, Paolo Malvezzi, Lionel Rostaing
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Journal of Clinical Medicine
Subjects:
desensitization
kidney transplantation
tocilizumab
anti-HLA alloantibodies
MFI
Online Access:https://www.mdpi.com/2077-0383/12/2/424

Internet

https://www.mdpi.com/2077-0383/12/2/424

Similar Items